Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are $225,000 over a three year period. We are delighted to welcome these brilliant investigators to our Gabrielle’s Angels family! Stay tuned for spotlights on each grantee and their work throughout the rest of the […]

https://patch.com/new-jersey/newbrunswick/500k-grant-supports-exploration-therapies-rare-lymphomas

We are delighted to welcome Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research! Sarah K Tasian, MD is a pediatric oncologist and physician-scientist at the Children’s Hospital of Philadelphia (CHOP) and an Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine who is interested in […]

From the lab of Gabrielle’s Angels grantee Iannis Aifantis – their latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such as acute myeloid leukemia (AML), do not respond or […]

We are thrilled to announce that we have selected the recipients of our first ever Mark Foundation – Gabrielle’s Angel Foundation Collaborative Grants. Co-funded with the Mark Foundation for Cancer Research, these two projects totaling $1M represent an amazing opportunity for us to re-invest in our grantees’ impactful work while helping to accelerate progress by bringing together scientists and institutions for collaboration. We are so grateful for […]

Congratulations to Zuzana Tothova, MD, PhD (Gabrielle’s Angels Grantee 2022) who is the recipient of the Doris Duke Foundation‘s Paragon Award for Research Excellence! This one-time recognition honors physician-scientists who have significantly advanced knowledge toward the prevention, diagnosis, and treatment of human disease or who have, through their professional contributions, improved the health outcomes of […]

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier. This assay may improve detection of AML driven by KMT2A gene fusions and may affect treatment decision-making, assessing response […]

Daniel Herranz Benito, an associate professor in the Department of Pharmacology, recently received an $800,000 grant from the V Foundation for Cancer Research to further research T cell Acute Lymphoblastic Leukemia (T-ALL). Benito, who is also a resident researcher at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Barnabas Health, said this four-year grant will allow him […]

Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are $225,000 over a three year period. We are delighted to welcome these brilliant investigators to our Gabrielle’s Angels family! Stay tuned for spotlights on each grantee and their work throughout the […]

New research from Gabrielle’s Angels grantees Cigall Kadoch and Iannis Aifantis shows the commanding role of BAF complexes in mediating T cell exhaustion. Targeting these complexes could reduce exhaustion & give CAR T cells more staying power to take on cancer. Read the full article here.

We are delighted to welcome Dr. Eirini Papapetrou to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research!  Dr. Papapetrou  is a Professor of Oncological Sciences, Hematology and Medical Oncology and founding Director of the Center for Advancement of Blood Cancer Therapies at the Icahn School of Medicine at Mount Sinai. She obtained MD and […]

Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Because of the poor outcomes of this disease, researchers across the globe have been on the hunt for new ways to treat AML, while preserving normal blood development. Researchers at Baylor College of Medicine and collaborating institutions report […]